12-111598942-G-GGGC
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 1P and 6B. PM4_SupportingBP6_ModerateBS2
The NM_001372574.1(ATXN2):c.90_92dupGCC(p.Pro31dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000122 in 1,461,936 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.00024 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00011 ( 0 hom. )
Consequence
ATXN2
NM_001372574.1 disruptive_inframe_insertion
NM_001372574.1 disruptive_inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.985
Genes affected
ATXN2 (HGNC:10555): (ataxin 2) This gene belongs to a group of genes that is associated with microsatellite-expansion diseases, a class of neurological and neuromuscular disorders caused by expansion of short stretches of repetitive DNA. The protein encoded by this gene has two globular domains near the N-terminus, one of which contains a clathrin-mediated trans-Golgi signal and an endoplasmic reticulum exit signal. The encoded cytoplasmic protein localizes to the endoplasmic reticulum and plasma membrane, is involved in endocytosis, and modulates mTOR signals, modifying ribosomal translation and mitochondrial function. The N-terminal region of the protein contains a polyglutamine tract of 14-31 residues that can be expanded in the pathogenic state to 32-200 residues. Intermediate length expansions of this tract increase susceptibility to amyotrophic lateral sclerosis, while long expansions of this tract result in spinocerebellar ataxia-2, an autosomal-dominantly inherited, neurodegenerative disorder. Genome-wide association studies indicate that loss-of-function mutations in this gene may be associated with susceptibility to type I diabetes, obesity and hypertension. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
PM4
Nonframeshift variant in NON repetitive region in NM_001372574.1. Strenght limited to Supporting due to length of the change: 1aa.
BP6
Variant 12-111598942-G-GGGC is Benign according to our data. Variant chr12-111598942-G-GGGC is described in ClinVar as [Benign]. Clinvar id is 2643321.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 24 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATXN2 | NM_001372574.1 | c.90_92dupGCC | p.Pro31dup | disruptive_inframe_insertion | Exon 1 of 25 | ENST00000673436.1 | NP_001359503.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATXN2 | ENST00000673436.1 | c.90_92dupGCC | p.Pro31dup | disruptive_inframe_insertion | Exon 1 of 25 | NM_001372574.1 | ENSP00000500925.1 |
Frequencies
GnomAD3 genomes AF: 0.000236 AC: 24AN: 101758Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
24
AN:
101758
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000300 AC: 25AN: 83364Hom.: 0 AF XY: 0.000423 AC XY: 20AN XY: 47254
GnomAD3 exomes
AF:
AC:
25
AN:
83364
Hom.:
AF XY:
AC XY:
20
AN XY:
47254
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000114 AC: 155AN: 1360086Hom.: 0 Cov.: 30 AF XY: 0.000146 AC XY: 98AN XY: 671002
GnomAD4 exome
AF:
AC:
155
AN:
1360086
Hom.:
Cov.:
30
AF XY:
AC XY:
98
AN XY:
671002
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000236 AC: 24AN: 101850Hom.: 0 Cov.: 31 AF XY: 0.000330 AC XY: 16AN XY: 48412
GnomAD4 genome
AF:
AC:
24
AN:
101850
Hom.:
Cov.:
31
AF XY:
AC XY:
16
AN XY:
48412
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
May 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
ATXN2: BS1, BS2 -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at